Track your holdings and dividends manually for free. Subscribe to link your brokerage through Plaid and automatically sync holdings and dividend payments.
Data last updated: Nov 12, 2026
Snapshot (as of Nov 12, 2026): Cencora, Inc. (COR) pays a $2.40 annual dividend ($0.60 quarterly), yielding 0.75% at $349.88/share. Next ex-dividend date 2026-11-13. Source: Yahoo Finance, aggregated by MerryDiv.
Dividend Yield: 0.75%
Annual Dividend: $2.40 per share
Payout Ratio: 17.4%
Ex-Dividend Date: 2026-11-13
Dividend Frequency: quarterly
Sector: Healthcare
Years of Dividend History: 26
Cencora, Inc. dividend comes from one of the largest pharmaceutical distributors in the United States, supplying generic drugs, specialty biologics, and oncology products to hospitals, retail pharmacies, and health systems. The current yield is 0.79%, with trailing annual payments of $2.40 per share paid quarterly. The next ex-dividend date is November 13, 2026. COR stock carries a beta of 0.571, which means it moves well below the broader market, a characteristic that appeals to investors who prioritize capital preservation over high income.
Cencora, Inc. pays out 17.4% of earnings as dividends, a payout ratio classified as conservative (below 40%). That low figure reflects a business built on high-volume pharmaceutical distribution to hospitals, retail pharmacies, and specialty care providers, where demand is driven by prescription volume rather than discretionary spending. Cencora, Inc. dividend safety looks strong on a payout basis, though the company operates on thin distribution margins, which means earnings are sensitive to pricing pressure from manufacturers and large pharmacy customers. That margin structure is the most data-supported factor that could pressure the dividend over time.
Cencora, Inc. dividend history shows a CAGR of 5.8% per year from 2007 to 2025. Per-share payments grew from $0.81 to $2.25 over that period (2026 is a partial year and excluded from the CAGR calculation). The largest annual increase in the window was 63.8% in 2015. The data also contains at least one year-over-year decline exceeding 5%, so growth has not been linear across the full history.
| Period | CAGR | From | To |
|---|---|---|---|
| 3-Year | +6.5% | $1.86 (2022) | $2.25 (2025) |
| 5-Year | +5.8% | $1.70 (2020) | $2.25 (2025) |
| 10-Year | +3.3% | $1.63 (2015) | $2.25 (2025) |
COR stock fits dividend investors who want low volatility and a well-covered payout rather than high current income. The yield is low (below 2%) at 0.79%, sitting below the 5-year average of 0.91%, which means buyers today are getting less income than the historical norm. The payout ratio of 17.4% leaves substantial room for future increases, and the 5.8% annual growth rate over 18 years shows the company has expanded its dividend meaningfully over time. The trade-off is straightforward: income is modest now, but the payout is backed by a large, demand-driven pharmaceutical distribution business with a beta well below 1.
| Payment Date | Amount per Share |
|---|---|
| 2026-08-14 | $0.6000 |
| 2026-05-15 | $0.6000 |
| 2026-02-13 | $0.6000 |
| 2025-11-14 | $0.6000 |
| 2025-08-15 | $0.5500 |
| 2025-05-16 | $0.5500 |
| 2025-02-14 | $0.5500 |
| 2024-11-15 | $0.5500 |
| 2024-08-09 | $0.5100 |
| 2024-05-09 | $0.5100 |
| Year | Total Dividends |
|---|---|
| 2026 | $1.8000 |
| 2025 | $2.2500 |
| 2024 | $2.0800 |
| 2023 | $1.9650 |
| 2022 | $1.8650 |
Project income from COR with the COR dividend calculator or track your full portfolio with the dividend tracker.